Wells Fargo analyst Elyse Greenspan maintained a Buy rating on Globe Life (GL – Research Report) today and set a price target of $132.00. The company’s shares closed yesterday at $104.93.
Greenspan covers the Financial sector, focusing on stocks such as Allstate, Progressive, and Axis Capital. According to TipRanks, Greenspan has an average return of 10.1% and a 63.13% success rate on recommended stocks.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Globe Life with a $132.10 average price target, representing a 25.89% upside. In a report released on April 5, Piper Sandler also maintained a Buy rating on the stock with a $130.00 price target.
The company has a one-year high of $131.71 and a one-year low of $101.40. Currently, Globe Life has an average volume of 793.9K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Globe Life (GL) Company Description:
Globe Life, Inc. is a holding company, which engages in the provision of individual life and supplemental health insurance products and services. It operates through the following segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. The Life Insurance segment includes traditional and interest-sensitive whole life insurance as well as term life insurances. The Supplement Health Insurance segment provides generally guaranteed-renewable and include medicare supplement, critical illness, accident, and limited-benefit supplemental hospital, and surgical coverage. The Annuities segment refers to fixed-benefit contracts. The Investments segment covers the investment portfolio. The company was founded on November 19, 1979 and is headquartered in McKinney, TX.
Read More on GL:
